Clinical Trials
129 trialsFocal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
Jonsson Comprehensive Cancer Center
MRI-guided Locoregional SBRT Prostate Program
Clinica Universidad de Navarra, Universidad de Navarra
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
St. Jude Children's Research Hospital
Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer
Brigham and Women's Hospital
MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer
M.D. Anderson Cancer Center
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Stanford University
Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy
H. Lee Moffitt Cancer Center and Research Institute
VESICOL
Institut de Cancérologie de Lorraine
HypoRTCx-UG
Uganda Cancer Institute
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Accelerated Partial Breast Irradiation Following Lumpectomy for Breast Cancer
Stanford University
Pembrolizumab With Locally Delivered Radiation Therapy for the Treatment of Metastatic Esophageal Cancers
Washington University School of Medicine
TEP-Curie
Centre Oscar Lambret
Brachytherapy for Prostatic Carcinoma Patients
M.D. Anderson Cancer Center
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
The Methodist Hospital Research Institute
Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Jonsson Comprehensive Cancer Center
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
St. Jude Children's Research Hospital
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation
Thomas Jefferson University
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
Emory University
REVELUTION
Emory University
Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies
Jonsson Comprehensive Cancer Center
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
Washington University School of Medicine
Hypofractionated Radiochemotherapy
University of Kentucky
SAVE
University of Utah
Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer
University of Nebraska
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
Memorial Sloan Kettering Cancer Center
Surgical Resection and Intraoperative Cesium-131 Brachytherapy for Head and Neck Cancer
Thomas Jefferson University
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer
Rutgers, The State University of New Jersey
MELCOM
Hospital das Clínicas de Ribeirão Preto
High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer
Thomas Jefferson University
BRIGHT-ESCC
National Taiwan University Hospital
MRI-guided Brachytherapy and Salvage SBRT Program
Clinica Universidad de Navarra, Universidad de Navarra
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
St. Jude Children's Research Hospital
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer
Jonsson Comprehensive Cancer Center
HYDRA
Jonsson Comprehensive Cancer Center
Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer
University of Virginia
Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer
Peking Union Medical College Hospital
FocaSaBra
The Greater Poland Cancer Centre
PARCERII
Tata Memorial Centre
IP4-CHRONOS
Imperial College London
A Clinical Study of Pelvic Concurrent Chemoradiotherapy Combined with CT-guided Intracavitary Brachytherapy with Adaptive Simultaneous Dose Escalation for Locally Advanced Cervical Cancer
Peking University Third Hospital
SCRIPBOT
Sir Run Run Shaw Hospital
Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer
Icahn School of Medicine at Mount Sinai
PRISCILLA
Istituto Clinico Humanitas
Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC
Tongji Hospital
Intraoperative Radiation Therapy for Locally Advanced or Recurrent Abdomino-pelvic Solid Tumors With the CivaSheet
Memorial Sloan Kettering Cancer Center
Single High-dose Brachytherapy for Giant Osteosarcoma Masses
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma
St. Jude Children's Research Hospital